Patent · US Active

Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications

US11041173B2 · kind B2 · utility

49Cited by
23References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 11, 2016
Grant dateJun 22, 2021
Priority date
Expiry dateNov 11, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B30/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides for delivery, engineering and optimization of systems, methods, and compositions for manipulation of sequences and/or activities of target sequences. Provided are delivery systems and tissues or organ which are targeted as sites for delivery. Also provided are vectors and vector systems some of which encode one or more components of a CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods of directing CRISPR complex formation in eukaryotic cells to ensure enhanced specificity for target recognition and avoidance of toxicity and to edit or modify a target site in a genomic locus of interest to alter or improve the status of a disease or a condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.